Tumor necrosis factor-alpha blocker induced tuberculosis.
Kharbanda
Priyanka
P
Dagaonkar
Rucha
R
Balakrishnan
Canchi
C
Udwadia
Zarir F
ZF
D000293:Adolescent; D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002648:Child; D006801:Humans; D000069285:Infliximab; D055985:Latent Tuberculosis / Q000175:diagnosis / Q000209:etiology* / Q000276:immunology; D008297:Male; D012216:Rheumatic Diseases / Q000188:drug therapy / Q000276:immunology; D014374:Tuberculin Test; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab